Medicover AB (publ) (MCOV-B.ST)

SEK 242.0

(0.21%)

EBITDA Summary of Medicover AB (publ)

Medicover AB (publ)'s latest annual EBITDA in 2023 was 257.4 Million EUR , up 16.27% from previous year.
Medicover AB (publ)'s latest quarterly EBITDA in 2024 Q2 was 71.5 Million EUR , up 6.17% from previous quarter.
Medicover AB (publ) reported an annual EBITDA of 215.9 Million EUR in 2022, down -21.86% from previous year.
Medicover AB (publ) reported an annual EBITDA of 274.9 Million EUR in 2021, up 77.33% from previous year.
Medicover AB (publ) reported a quarterly EBITDA of 69.2 Million EUR for 2024 Q1, down -34.99% from previous quarter.
Medicover AB (publ) reported a quarterly EBITDA of 60.3 Million EUR for 2023 Q3, down -9.05% from previous quarter.

Annual EBITDA Chart of Medicover AB (publ) (2023 - 2014)

Historical Annual EBITDA of Medicover AB (publ) (2023 - 2014)

Year	EBITDA	EBITDA Growth
2023	257.4 Million EUR	16.27%
2022	215.9 Million EUR	-21.86%
2021	274.9 Million EUR	77.33%
2020	151.6 Million EUR	19.44%
2019	121.2 Million EUR	109.71%
2018	61.8 Million EUR	4.57%
2017	52.8 Million EUR	47.01%
2016	40.2 Million EUR	6.91%
2015	38.2 Million EUR	11.24%
2014	33.4 Million EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	71.5 Million EUR	6.17%
2024 Q1	69.2 Million EUR	-34.99%
2023 Q3	60.3 Million EUR	-9.05%
2023 Q4	72.3 Million EUR	19.9%
2023 Q2	66.3 Million EUR	13.33%
2023 Q1	58.5 Million EUR	1.56%
2023 FY	- EUR	16.27%
2022 Q2	49.7 Million EUR	-23.18%
2022 FY	- EUR	-21.86%
2022 Q1	64.7 Million EUR	-16.3%
2022 Q4	57.6 Million EUR	30.32%
2022 Q3	44.2 Million EUR	-11.07%
2021 FY	- EUR	77.33%
2021 Q4	77.3 Million EUR	33.51%
2021 Q3	57.9 Million EUR	-22.9%
2021 Q2	75.1 Million EUR	16.25%
2021 Q1	64.6 Million EUR	16.19%
2020 FY	- EUR	19.44%
2020 Q1	24.7 Million EUR	-42.56%
2020 Q2	26.3 Million EUR	6.48%
2020 Q3	48.2 Million EUR	83.27%
2020 Q4	55.6 Million EUR	15.35%
2019 Q4	43 Million EUR	36.51%
2019 Q1	28.1 Million EUR	74.53%
2019 Q3	31.5 Million EUR	16.67%
2019 FY	- EUR	109.71%
2019 Q2	27 Million EUR	-3.91%
2018 FY	- EUR	4.57%
2018 Q4	16.1 Million EUR	0.63%
2018 Q3	16 Million EUR	-5.33%
2018 Q2	16.9 Million EUR	-12.44%
2018 Q1	19.3 Million EUR	1.05%
2017 Q4	19.1 Million EUR	39.42%
2017 Q3	13.7 Million EUR	16.1%
2017 FY	- EUR	47.01%
2017 Q2	11.8 Million EUR	-19.18%
2017 Q1	14.6 Million EUR	39.05%
2016 Q2	7.5 Million EUR	-21.05%
2016 Q1	9.5 Million EUR	0.0%
2016 Q4	10.5 Million EUR	-17.32%
2016 Q3	12.7 Million EUR	69.33%
2016 FY	- EUR	6.91%
2015 FY	- EUR	11.24%
2014 FY	- EUR	0.0%

Peer EBITDA Comparison of Medicover AB (publ)

Name	EBITDA	EBITDA Difference
Ambea AB (publ)	2.28 Billion SEK	88.715%
Attendo AB (publ)	3.11 Billion SEK	91.737%
Humana AB (publ)	457 Million SEK	43.676%
ProstaLund AB (publ)	-16.57 Million SEK	1653.222%